TY - GEN
T1 - Stroke management cost
T2 - 3rd International Symposium of Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2018
AU - Wijaya, Hendy Risdianto
AU - Supriyanto, Eko
AU - Salim, Maheza Irna Mohamad
AU - Siregar, Kemal N.
AU - Eryando, Tris
N1 - Publisher Copyright:
© 2019 Author(s).
PY - 2019/4/9
Y1 - 2019/4/9
N2 - Stroke is one of the most common killers in Indonesia, Malaysia and Singapore. The mortality rate due to stroke in Indonesia is around 192/100.000, 84/100.000 and 47.9/100.000 for Malaysia and Singapore respectively in last 5 years. Treatment time, cost and quality are believed as main factors contributing to high mortality and disability caused by stroke. This paper presents the relation between stroke management cost, mortality rate and disability rate in Indonesia, Malaysia and Singapore. We used stroke epidemiological data in Indonesia, Malaysia and Singapore for last 12 years. This includes stroke prevalence, incidence, mortality and disability. Normalized clinical pathway for stroke management is used to define cost, quality and treatment duration. Administration, imaging, diagnosis, medication, intensive care, in ward recovery and outpatient rehabilitation are parts in stroke management system. We consider also country specific Gross Domestic Product (GDP per capita) and percentage of national health expenditure to justify the stroke management cost level. All related factors contributed directly and indirectly to the cost are connected through relationship trees model. The model has been simulated to produce normalized country specific cost, mortality-prevalence ratio, and disability-prevalence ratio. Simulation results show that normalized country specific costs for stroke management each one day care are 2.52% for Malaysia, 0.65% for Singapore and 3.88% for Indonesia. Based on this cost, Malaysia is able to have mortality-prevalence ratio and disability-prevalence ratio of 0.12 and 2.11 respectively. As country with highest GDP per capita, Singapore has successfully managed to have 0.01 and 0.22 mortality-prevalence ratio and disability-prevalence ratio respectively. Indonesia, however, with stroke management cost higher than Malaysia, is only able to suppress the mortality-prevalence ratio up to 0.16 and disability-prevalence ratio up to 2.80. This shows that stroke management system in Indonesia needs to be improved.
AB - Stroke is one of the most common killers in Indonesia, Malaysia and Singapore. The mortality rate due to stroke in Indonesia is around 192/100.000, 84/100.000 and 47.9/100.000 for Malaysia and Singapore respectively in last 5 years. Treatment time, cost and quality are believed as main factors contributing to high mortality and disability caused by stroke. This paper presents the relation between stroke management cost, mortality rate and disability rate in Indonesia, Malaysia and Singapore. We used stroke epidemiological data in Indonesia, Malaysia and Singapore for last 12 years. This includes stroke prevalence, incidence, mortality and disability. Normalized clinical pathway for stroke management is used to define cost, quality and treatment duration. Administration, imaging, diagnosis, medication, intensive care, in ward recovery and outpatient rehabilitation are parts in stroke management system. We consider also country specific Gross Domestic Product (GDP per capita) and percentage of national health expenditure to justify the stroke management cost level. All related factors contributed directly and indirectly to the cost are connected through relationship trees model. The model has been simulated to produce normalized country specific cost, mortality-prevalence ratio, and disability-prevalence ratio. Simulation results show that normalized country specific costs for stroke management each one day care are 2.52% for Malaysia, 0.65% for Singapore and 3.88% for Indonesia. Based on this cost, Malaysia is able to have mortality-prevalence ratio and disability-prevalence ratio of 0.12 and 2.11 respectively. As country with highest GDP per capita, Singapore has successfully managed to have 0.01 and 0.22 mortality-prevalence ratio and disability-prevalence ratio respectively. Indonesia, however, with stroke management cost higher than Malaysia, is only able to suppress the mortality-prevalence ratio up to 0.16 and disability-prevalence ratio up to 2.80. This shows that stroke management system in Indonesia needs to be improved.
KW - Clinical pathway
KW - mortality rate
KW - stroke cost
KW - stroke management
KW - stroke prevalence
UR - http://www.scopus.com/inward/record.url?scp=85064834049&partnerID=8YFLogxK
U2 - 10.1063/1.5096726
DO - 10.1063/1.5096726
M3 - Conference contribution
AN - SCOPUS:85064834049
T3 - AIP Conference Proceedings
BT - 3rd Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices
A2 - Wulan, Praswasti P.D.K.
A2 - Gozan, Misri
A2 - Astutiningsih, Sotya
A2 - Ramahdita, Ghiska
A2 - Dhelika, Radon
A2 - Kreshanti, Prasetyanugraheni
PB - American Institute of Physics Inc.
Y2 - 6 August 2018 through 8 August 2018
ER -